Esophageal Cancer Surgical Outcomes

Esophageal cancer remains a formidable challenge in global oncology, with surgical resection constituting the cornerstone of curative treatment for locally advanced disease. Outcomes after oesophagectomy are defined by a balance between oncological control and perioperative risk. Radical resection with adequate lymphadenectomy (often two- or three-field) offers the best chance of eradicating locoregional tumour deposits, but is associated with substantial morbidity, including pulmonary complications, anastomotic leakage and cardiovascular events. Advances in perioperative care, patient selection, neoadjuvant therapy and surgical technique have gradually reduced in-hospital mortality to below 5–10 per cent in high-volume centres. Long-term survival at five years now approaches 40–50 per cent among patients achieving R0 resection, although recurrence and late complications continue to impact quality of life. Minimally invasive and hybrid approaches have been developed to reduce operative trauma, and modern imaging techniques now aid intraoperative decision-making to improve conduit perfusion and minimise leak rates. Centralisation of care and multidisciplinary management have further enhanced outcomes by concentrating expertise and standardising protocols for enhanced recovery. As the field moves forward, the integration of robotic platforms, fluorescence-guided perfusion assessment and refined postoperative pathways promises further gains in safety and survival.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Esophageal Cancer Surgical Outcomes publication trend

The graph below shows the total number of articles in esophageal cancer surgical outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Esophagectomy: Surgical removal of all or part of the oesophagus, often with reconstruction using a gastric or colonic conduit.

Anastomotic leakage: Breakdown of the surgical connection between oesophagus and conduit, resulting in leakage of luminal contents and risk of sepsis.

Minimally invasive oesophagectomy (MIO): Laparoscopic or thoracoscopic approach to oesophagectomy aiming to reduce surgical trauma and enhance recovery.

R0 resection: Complete tumour removal with microscopically negative margins, indicating no residual cancer at the cut edges.

Lymphadenectomy: Surgical removal of lymph nodes in the mediastinum and abdomen to assess and control regional metastatic spread.

References

1. Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis. World Journal of Surgical Oncology (2016).
2. Meta-analysis of the impact of postoperative complications on survival after oesophagectomy for cancer. BJS Open (2018).
3. Blood flow speed of the gastric conduit assessed by indocyanine green fluorescence. Medicine (2016).